Alan Korman

Author PubWeight™ 22.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A 2003 5.49
2 Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A 2008 4.43
3 Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors. Clin Cancer Res 2009 2.97
4 Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy. Semin Oncol 2010 2.51
5 PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol 2009 2.10
6 High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol 2008 1.79
7 Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques. J Immunol 2003 1.54
8 Enhanced protein production by engineered zinc finger proteins. Biotechnol Bioeng 2007 1.26
9 PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation. Cancer Res 2011 1.24